Total
USD $0.00
 
China

Company Overview of Shanghai Pharmaceuticals Holding Co., Ltd. (上海医药集团股份有限公司)

An EMIS Company Report EMIS is an ISI Emerging Markets Group Company Company Description

Shanghai Pharmaceuticals Holding Co., Ltd is a national pharmaceutical group. The Company is principal egaged in pharmaceutical R&D, manufacturing, distribution and retailing. Its main products include biopharmaceuticals, chemical and Chinese traditional medicines, and healthcare products. The company was founded in 1994 and is headquartered in Shanghai.

Need a report on this company? USD 29.95 Industry: Drugs and Druggists' Sundries Merchant Wholesalers Available in: English & Chinese Format: PDF Download Most recent financial data: 2017 Buy full report

Report contents

On purchasing the report for this company you will have access to a PDF containing the most recent data for Shanghai Pharmaceuticals Holding Co., Ltd. from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
NAICS Industry Classification
Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Contact Information

Headquarters
92 Zhangjiang Road Free Trade Testing Zone Shanghai
Taicang; Jiangsu; Postal Code: 200020

Tel: 86-21-6373
Fax: 86-21-6328

Email:
@sphchina.com

Website:
http://www.sphchina.com

Basic Information
Total Employees:
42,236 (2017)
Outstanding Shares:
Provided in the purchased report
Registered Capital:
Provided in the purchased report
Financial Auditors:
Provided in the purchased report
Incorporation Date:
January 18, 1994
Key Executives
Provided in the purchased report
Chairman
Provided in the purchased report
Executive Director
Provided in the purchased report
Chairman of the Supervisory Board
Provided in the purchased report
Representative of Securities Affairs
Provided in the purchased report
President
More
Ownership Details
HKSCC Nominees Limited
27.81%
上海医药(集团)有限公司
26.65%
上海实业(集团)有限公司及其全资附属子公司及上海上实(集团)有限公司
8.87%
Shanghai Shengrui Investment Co.,Ltd.
4.44%
Shenergy Group Co., Ltd.
3.02%
More
Subsidiaries
Beijing Xinhai Fengyuan Bio. Pharmaceutical Sci. & Tech. Dev. Ltd.
100%
Shanghai China Pharmaceutical Ltd.
100%
Shanghai Pharmaceutical Goods Supplies & Sales Ltd.
100%
More
M&A deals (Not included in report)
China Isotope & Radiation raises USD 220.2mn in its Hong Kong IPO
05-Jul-18 | IPO - 220.22 USD Millions - 25.00% stake
Japanese global pharmaceutical giant Takeda exits Chinese JV Techpool
21-May-18 | Acquisition - 280.00 USD Millions - 51.34% stake
Shanghai Pharmaceuticals Holding sells Shanghai Huashi Asset Management for USD 33mn
20-Dec-17 | Acquisition - 33.00 USD Millions - 100.00% stake

Report contents

On purchasing the report for this company you will have access to a PDF containing the most recent data for Shanghai Pharmaceuticals Holding Co., Ltd. from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
Key Financial Highlights
Annual growth percentages* for latest two years in USD terms. Absolute financial data is included in the purchased report.
Net sales revenue
31.06%
Total operating revenue
31.82%
Operating profit (EBIT)
44.77%
EBITDA
39.24%
Net Profit (Loss) for the Period
35.22%
Total assets
49.63%
Total equity
24.18%
Operating Profit Margin (ROS)
0.38%
Net Profit Margin
0.1%
Return on Equity (ROE)
0.4%
Debt to Equity Ratio
29.63%
Quick Ratio
-16.95%
Cash Ratio
-19.36%
* Growth figures are affected by the currency rate changes.
Company News (Not included in report)
Industry News (Not included in report)
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Request a demonstration of the EMIS service

To view more information, Request a demonstration of the EMIS service